Deubiquitinase OTUD4 Stabilizes SLC5A2 to Promote Pancreatic Cancer Proliferation and Migration Through Enchaining Glycolysis‐Mediated Autophagy
The FASEB Journal · 2025
DOI: 10.1096/fj.202501018r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Xin Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Province Key Laboratory of Pollution Damage and Biological Control for Huaihe River Basin, Fuyang Normal University, Fuyang, Anhui, People's Re…. Hauptthemen laut MEDLINE: Glycolysis, Pancreatic Neoplasms, Cell Proliferation, Autophagy. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Fuyang Normal University, The National Natural Science Foundation of China, Fuyang People's Hospital.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized by its insidious onset, rapid progression, and poor treatment outcomes. Sodium glucose transporter 2 (SLC5A2) is the predominant sodium‐glucose transporter. Our study reveals that SLC5A2 interacted with ovarian tumor family deubiquitinase 4 (OTUD4) to stabilize and increase its expression in PDAC. SLC5A2 overexpression promoted pancreatic cancer cell proliferation in vitro and in vivo, while also promoting cell migration, invasion, and autophagy. Conversely, SLC5A2 knockdown reversed these effects. RNA‐seq and GSEA revealed that glycolysis pathway activation was inhibited following SLC5A2 knockdown. Consistent with this, qRT‐PCR and western blot analyses indicated reduced glycolysis‐related gene expression levels. Metabolomics further revealed that knockdown of SLC5A2 decreased intermediate product levels in glycolysis, as well as glucose intake. Glycolysis inhibitor (2‐DG) amplified the effect of SLC5A2 knockdown in promoting autophagy, resulting in decreased pancreatic cancer proliferation, migration, and invasion. Notably, the antitumor effects of SLC5A2 knockdown were reversed by Bafilomycin A1. Additionally, treatment with the SLC5A2 inhibitor, canagliflozin (CANA), inhibited pancreatic cancer growth by inhibiting glycolysis and enhancing autophagy in vitro/vivo. These findings suggest that SLC5A2 promotes pancreatic cancer progression by regulating the glycolysis‐autophagy axis, suggesting it as a therapeutic target for improving PDAC treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Anhui Province Key Laboratory of Pollution Damage and Biological Control for Huaihe River Basin, Fuyang Normal University, Fuyang, Anhui, People's Republic of China.
- The School of Biology and Food Engineering, Fuyang Normal University, Fuyang, Anhui, People's Republic of China.
- Department of Hepatobiliary and Pancreatic Surgery, Fuyang People's Hospital, Anhui Medical University, Fuyang, Anhui, People's Republic of China.
ORCID-Profile: Fengrui Wu
Förderung
- Fuyang Normal University
- The National Natural Science Foundation of China
- Fuyang People's Hospital
- National Natural Science Foundation of China
Zitieren
APA
Xie, X., Zhang, Y., Li, Y., Guo, N., Guo, X., Wang, F., Ren, K., Yu, J., & Wu, F. (2025). Deubiquitinase OTUD4 Stabilizes SLC5A2 to Promote Pancreatic Cancer Proliferation and Migration Through Enchaining Glycolysis‐Mediated Autophagy. The FASEB Journal. https://doi.org/10.1096/fj.202501018r
Vancouver
Xie X, Zhang Y, Li Y, Guo N, Guo X, Wang F, et al. Deubiquitinase OTUD4 Stabilizes SLC5A2 to Promote Pancreatic Cancer Proliferation and Migration Through Enchaining Glycolysis‐Mediated Autophagy. The FASEB Journal. 2025. doi:10.1096/fj.202501018r
BibTeX
@article{Xie2025,
author = {Xie, Xin and Zhang, Yadi and Li, Yuanyuan and Guo, Na and Guo, Xiaomeng and Wang, Feilong and Ren, Kuiwu and Yu, Jiangtao and Wu, Fengrui},
title = {Deubiquitinase OTUD4 Stabilizes SLC5A2 to Promote Pancreatic Cancer Proliferation and Migration Through Enchaining Glycolysis‐Mediated Autophagy},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202501018r}
}
EUVIMED